- Home
- INO vs ZBAI Comparison
INO vs ZBAI Comparison
Compare INO & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | ZBAI |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 95.5M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | ZBAI |
|---|---|---|
| Price | $1.18 | $8.95 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 5.5K |
| Earning Date | 05-08-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $20,156.19 | N/A |
| Revenue Next Year | $421.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.03 | $0.30 |
| 52 Week High | $2.86 | $11.94 |
Technical Indicators
Market Signals| Indicator | INO | ZBAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 59.03 |
| Support Level | $1.03 | $5.41 |
| Resistance Level | $1.23 | $9.49 |
| Average True Range (ATR) | 0.10 | 0.58 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 12.50 | 75.45 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial consulting services to small and medium-sized enterprises. It operates in one operating segment, which is the consulting service business. The company prominently generated revenues from consulting services to its clients. Geographically, the maximum revenue is derived from Hong Kong.